NASDAQ
Harmony Biosciences Holdings, Inc. (HRMY) has a free cash flow growth of -77.98% as of Friday, May 29, 2026. This represents a 335.62% decrease compared to its 12-month average of 33.09%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.